SiBone (SIBN) & Its Rivals Critical Analysis

SiBone (NASDAQ:SIBN) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it contrast to its competitors? We will compare SiBone to related companies based on the strength of its valuation, profitability, analyst recommendations, institutional ownership, risk, earnings and dividends.

Risk and Volatility

SiBone has a beta of 0.64, indicating that its share price is 36% less volatile than the S&P 500. Comparatively, SiBone’s competitors have a beta of 2.57, indicating that their average share price is 157% more volatile than the S&P 500.

Earnings and Valuation

This table compares SiBone and its competitors revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
SiBone	$200.93 million	-$18.90 million	-80.97
SiBone Competitors	$1.89 billion	$136.85 million	12.52

SiBone’s competitors have higher revenue and earnings than SiBone. SiBone is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a breakdown of recent recommendations for SiBone and its competitors, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SiBone	1	0	7	0	2.75
SiBone Competitors	4288	10570	18345	830	2.46

SiBone currently has a consensus target price of $25.00, suggesting a potential downside of 0.40%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.20%. Given SiBone’s competitors higher probable upside, analysts plainly believe SiBone has less favorable growth aspects than its competitors.

Profitability

This table compares SiBone and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SiBone	-6.20%	-7.57%	-5.55%
SiBone Competitors	-304.10%	-178.81%	-22.11%

Insider & Institutional Ownership

98.1% of SiBone shares are held by institutional investors. Comparatively, 40.6% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 4.0% of SiBone shares are held by insiders. Comparatively, 15.0% of shares of all “Healthcare Equipment & Supplies” companies are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

SiBone competitors beat SiBone on 7 of the 13 factors compared.

SiBone Company Profile

SI-BONE, Inc. is a medical technology company focused on surgical solutions for conditions affecting the sacroiliac (SI) joint and related pelvic anatomy. Founded in 2008, the company develops implants and instruments used by surgeons in procedures involving the SI joint. Its products include the iFuse Implant System, a minimally invasive approach to SI joint fusion, along with related implant systems designed for SI joint and pelvic fixation procedures. SI-BONE also offers surgical instruments and training resources for healthcare professionals.